Drug
Hx575 For S C Administration
Hx575 For S C Administration: highest development phase Phase 3, developed by Sandoz. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| HX575 solution for s.c. administration NCT00869856 | Phase 3 | Anemia |
Latest
No recent events.
Follow Hx575 For S C Administration on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.